ANEBULO PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Earnings Per Share, Basic and Diluted of -$0.05 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-11
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.05.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.77.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.68.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.83.
| Period end | Earnings Per Share, Basic and Diluted 2 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$0.05 10-Q · filed 2022-02-11 | -$0.11 10-Q · filed 2022-02-11 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-09-09 | -$2.57 derived: net income ÷ weighted average shares · filed 2022-09-09 | -$2.83 10-K · filed 2021-09-22 | ||
| 2021-03-31 | -$0.68 10-Q · filed 2021-06-21 | -$0.74 10-Q · filed 2021-06-21 | |||
| 2020-12-31 | -$0.03 10-Q · filed 2022-02-11 | $0.05 10-Q · filed 2022-02-11 | |||
| 2020-09-30 | -$0.02 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | -$0.01 10-K · filed 2021-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |